Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Choyke

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
International Urology and Nephrology|December 7, 2019
Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsyDordaneh Sugano, Abhinav Sidana, Amit L Jain, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
IEEE Transactions on Medical Imaging|July 12, 2018
Deep Recurrent Neural Networks for Prostate Cancer Detection: Analysis of Temporal Enhanced UltrasoundShekoofeh Azizi, Sharareh Bayat, Pingkun Yan, et al.
World Journal of Oncology|November 18, 2017
Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate CancerChristine Ko, Holly Ning, Elena Lita, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2013
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumorsWoondong Jeong, Annamaria Rapisarda, Sook Ryun Park, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment RecommendationsAaron Reed, Luca F Valle, Uma Shankavaram, et al.
BJR Case Reports|September 14, 2020
Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment optionsAvinash R Chaurasia, Clayton P Smith, Peter Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2Christina M Annunziata, Amanda J Walker, Lori Minasian, et al.
Investigational New Drugs|November 19, 2013
Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumorsWoondong Jeong, Sook Ryun Park, Annamaria Rapisarda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2014
[¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrinsEsther Mena, Rikard Owenius, Baris Turkbey, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
International Urology and Nephrology|December 7, 2019
Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsyDordaneh Sugano, Abhinav Sidana, Amit L Jain, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
IEEE Transactions on Medical Imaging|July 12, 2018
Deep Recurrent Neural Networks for Prostate Cancer Detection: Analysis of Temporal Enhanced UltrasoundShekoofeh Azizi, Sharareh Bayat, Pingkun Yan, et al.
World Journal of Oncology|November 18, 2017
Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate CancerChristine Ko, Holly Ning, Elena Lita, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2013
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumorsWoondong Jeong, Annamaria Rapisarda, Sook Ryun Park, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment RecommendationsAaron Reed, Luca F Valle, Uma Shankavaram, et al.
BJR Case Reports|September 14, 2020
Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment optionsAvinash R Chaurasia, Clayton P Smith, Peter Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2Christina M Annunziata, Amanda J Walker, Lori Minasian, et al.
Investigational New Drugs|November 19, 2013
Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumorsWoondong Jeong, Sook Ryun Park, Annamaria Rapisarda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2014
[¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrinsEsther Mena, Rikard Owenius, Baris Turkbey, et al.
Pageof 17